Valuation dashboard for Progyny, Inc. (PGNY) with P/E 27.42, P/B 4.28, EV/EBITDA 15.02 and dividend yield 0.00%. DCF, Graham Number, EPS growth, peer multiples and dividend discount models plus sector comparison against other Healthcare companies.
Progyny, Inc. functions as a benefits management corporation, dedicated to providing specialized solutions for fertility and broader family-building initiatives to employers throughout the United States. Its core fertility offering is characterized by a distinctive benefits plan architecture, paired with personalized, white-glove member support services and access to a meticulously chosen network of top-tier fertility specialists.
Analysis Summary
Progyny, Inc. reported revenue of $1.29B in the most recent fiscal year, growing at a 5-year CAGR of 30.2%. Net income reached $58.5M, with a 4.7% 5-year CAGR.
Trailing-twelve-month margins: gross margin 24.6%, operating margin 8.6%, net margin 6.0%.
At the current price of $25.86, PGNY trades at a P/E of 27.42 and an ROE of 15.98%. Market capitalisation stands at $2.0B.
Balance sheet quality for PGNY: current ratio of 2.7. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| P/E Ratio | 27.42 |
| Price / Book | 4.28 |
| EV / EBITDA | 15.02 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $19.98 |
| vs Current Price | -22.7% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| PGNY | Progyny, Inc. | $2.0B | 27.42 | 4.28 | 16.0% |
| SDGR | Schrödinger, Inc. | $2.3B | 6.88 | -16.4% | |
| SEM | Select Medical Holdings Corporation | $2.0B | |||
| UNH | UnitedHealth Group Incorporated | $337.7B | 23.91 | 3.42 | 12.8% |
| 0HRS.L | CVS Health Corporation | $112.2B | |||
| CVS | CVS Health Corp. | $110.3B | 22.87 | 1.38 | 6.4% |
| 0HG8.L | Elevance Health, Inc. | $85.3B | |||
| ELV | Elevance Health Inc. | $83.8B | 17.17 | 1.88 | 12.9% |
Price
| Price | $25.86 |
| Market Cap | $2.0B |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | 15.98% |
| Return on Invested Capital | 15.32% |
| Return on Assets | 10.98% |
| Gross Margin | 24.57% |
| Operating Margin | 8.55% |
| Net Margin | 6.00% |
Related companies: ALVO · GDRX · OMCL · OMDA · PHR · SDGR
Explore sector: Healthcare · Medical - Healthcare Plans
More sections of PGNY: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks